Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Adding radial shock wave therapy to physical therapy for chronic low back pain

Official title: The Effect of Extracorporeal Shock Wave Therapy (ESWT) Added to Conservative Treatment on Pain, Disability, and Ultrasonographic Outcomes in Chronic Low Back Pain: A Randomized Controlled Trial

Run by Pamukkale University · NCT07132762 · Data updated 2026-11-12

This study tests whether adding radial extracorporeal shock wave therapy (ESWT) to standard physical therapy helps adults with chronic low back pain reduce pain, disability, and change ultrasound measures of back muscles.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment44 (estimated)
SponsorPamukkale University
Academic / other
Locations1 site (Denizli)
StatusRecruiting
StartedOctober 10, 2025
Main results expectedJuly 15, 2026
Study endsSeptember 15, 2026
Registry record updatedFebruary 6, 2026
Trial IDNCT07132762 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with non-specific low back pain lasting more than three months are the intended participants.

Probably not a fit

Patients with specific lumbar spine diseases (for example radicular pain or spinal stenosis), prior lumbar surgery or trauma, systemic muscle disorders, coagulopathy, pregnancy, active malignancy, or other listed exclusions are unlikely to benefit or will be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with non-specific chronic low back pain will receive conventional rehabilitation, and a group will also receive radial ESWT added to that program. Pain, disability questionnaires, and ultrasonographic measures including elastography of paraspinal muscles will be recorded at baseline and after the intervention. The trial compares changes between the group receiving ESWT plus rehab and the group receiving rehab alone to determine added effects. Outcomes will focus on patient-reported pain and function together with imaging-based muscle stiffness and morphology.

Why it matters

Potential benefit: If successful, adding ESWT could reduce pain and disability and improve back muscle function and ultrasound markers, helping patients resume daily activities more easily.

How similar studies have gone: ESWT has produced positive results in some other musculoskeletal conditions but evidence for chronic low back pain is limited and mixed, so this application is relatively novel with preliminary support.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Non-specific low back pain lasting more than three months

Exclusion Criteria:

* Specific lumbar spine diseases (radicular pain, spinal stenosis, infection)
* History of trauma, fracture, surgery, or presence of scar tissue in the lumbar region
* Presence of a disease that may affect muscle stiffness, such as collagen tissue disorders, hemiplegia, multiple sclerosis, or myopathies
* Malignancy, pregnancy, severe hypertension
* Coagulopathy, chronic heart disease
* Ankylosing spondylitis
* Diseases that may initially affect lumbar mobility and pain, such as leg length discrepancy, hip prosthesis, or scoliosis

Where it's running

  • Pamukkale University
    Denizli, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.